Real-world comparison of major bleeding and associated costs among treatment-naïve nonvalvular atrial fibrillation patients initiating apixaban or warfarin

Access
info:eu-repo/semantics/closedAccessDate
2016Author
Amin, AlpeshKeshishian, A
Xie L
Başer, Onur
Price, K
Vo, L
Mardekian, J
Mendoza, M
Singhal, S
Patel, C
Odell, K
Trocio, J
Metadata
Show full item recordCitation
Amin A, Keshishian A, Xie L, Baser O, Price K, Vo L, Mardekian J, Mendoza M, Singhal S, Patel C, Odell K, Trocio J. (August 27-31 , 2016). Real-world comparison of major bleeding and associated costs among treatment-naïve nonvalvular atrial fibrillation patients initiating apixaban or warfarin. European Society of Cardiology (ESC) Congress 2016. Rome, Italy.Abstract
...